Olga Frankfurt Selected Research

Lenalidomide (CC 5013)

3/2012

Final results of a multicenter phase 1 study of lenalidomide in patients with relapsed or refractory chronic lymphocytic leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Olga Frankfurt Research Topics

Disease

19	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2023 - 11/2007
8	Neoplasms (Cancer) 01/2023 - 07/2014
5	Leukemia 01/2022 - 11/2004
4	Hematologic Neoplasms (Hematological Malignancy) 01/2023 - 11/2004
4	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 11/2022 - 03/2012
3	Infections 01/2023 - 02/2007
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2023 - 12/2021
2	Febrile Neutropenia 01/2022 - 11/2014
2	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2021 - 12/2013
2	Neutropenia 10/2021 - 02/2007
2	Hodgkin Disease (Hodgkin's Disease) 01/2019 - 06/2014
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2014 - 11/2013
1	Hemoglobinopathies 01/2023
1	Fibrosis (Cirrhosis) 08/2019
1	Primary Myelofibrosis (Myelosclerosis) 08/2019
1	Splenomegaly 08/2019
1	Histiocytic Sarcoma 03/2019
1	Chromosome Aberrations (Chromosome Abnormalities) 03/2019
1	Pancreatitis 01/2018
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2017
1	Anemia 01/2017
1	Critical Illness (Critically Ill) 11/2014
1	Anterior Uveitis 08/2014
1	Exanthema (Rash) 12/2013
1	Erythema 12/2013
1	Folliculitis (Sycosis) 12/2013
1	Drug Eruptions (Drug Eruption) 12/2013
1	Acute Promyelocytic Leukemia 09/2013
1	Hemorrhage 09/2013
1	Disseminated Intravascular Coagulation 03/2009
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 02/2008
1	Mycoses (Diseases, Fungus) 04/2007
1	Bone Marrow Failure Disorders 02/2007
1	Lymphoma (Lymphomas) 11/2004

Drug/Important Bio-Agent (IBA)

4	Cytarabine (Cytosar-U)FDA LinkGeneric 12/2023 - 04/2012
3	Tyrosine Kinase InhibitorsIBA 01/2020 - 01/2014
3	Rituximab (Mabthera)FDA Link 01/2019 - 02/2008
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 12/2023 - 01/2021
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 11/2014
2	Mitoxantrone (Novantrone)FDA LinkGeneric 10/2021 - 04/2012
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 10/2021 - 02/2007
2	Azacitidine (5 Azacytidine)FDA Link 01/2021 - 01/2019
2	fms-Like Tyrosine Kinase 3IBA 01/2020 - 12/2013
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2019 - 08/2013
2	Alemtuzumab (Campath)FDA Link 01/2019 - 02/2015
2	Etoposide (VP 16)FDA LinkGeneric 08/2013 - 04/2012
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2011 - 02/2007
1	enasidenibIBA 12/2023
1	Monoclonal AntibodiesIBA 11/2022
1	Mitogen-Activated Protein KinasesIBA 01/2022
1	MDS1 and EVI1 Complex Locus ProteinIBA 01/2022
1	gilteritinibIBA 01/2022
1	selinexorIBA 12/2021
1	Biomarkers (Surrogate Marker)IBA 10/2021
1	alvocidib (flavopiridol)IBA 10/2021
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 10/2021
1	Calcineurin InhibitorsIBA 10/2021
1	ivosidenibIBA 01/2021
1	EnzymesIBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2020
1	pexidartinibIBA 01/2020
1	Aurora Kinase AIBA 08/2019
1	CytokinesIBA 08/2019
1	MLN 8237IBA 08/2019
1	ruxolitinibIBA 08/2019
1	Pentostatin (Nipent)FDA LinkGeneric 01/2019
1	Decitabine FDA Link 01/2019
1	venetoclaxIBA 01/2019
1	serum P-component (CIt)IBA 01/2019
1	blinatumomabIBA 01/2018
1	quizartinibIBA 01/2018
1	Hydroxyurea (Hydrea)FDA LinkGeneric 03/2015
1	Interleukin-3 Receptors (Interleukin 3 Receptor)IBA 07/2014
1	tagraxofuspIBA 07/2014
1	Mechanistic Target of Rapamycin Complex 1IBA 05/2014
1	Mechanistic Target of Rapamycin Complex 2IBA 05/2014
1	SteroidsIBA 12/2013
1	Ivermectin (Mectizan)FDA Link 12/2013
1	ponatinibIBA 11/2013
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 09/2013
1	Lipocalin-2IBA 08/2013
1	Lenalidomide (CC 5013)FDA Link 03/2012
1	HLA Antigens (Human Leukocyte Antigens)IBA 09/2009
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 09/2009
1	Dacarbazine (DIC)FDA LinkGeneric 03/2009
1	Voriconazole (Vfend)FDA LinkGeneric 04/2007
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 02/2007
1	GlucocorticoidsIBA 11/2004

Therapy/Procedure

17	Therapeutics 12/2023 - 04/2007
7	Drug Therapy (Chemotherapy) 01/2019 - 02/2007
5	Stem Cell Transplantation 03/2019 - 08/2013
2	Transplantation 01/2023 - 09/2009
2	Cell Transplantation 01/2023 - 01/2017
2	Lymphatic Irradiation 01/2019 - 06/2014
1	Induction Chemotherapy 10/2021